Meningococcemia in a vaccinated child receiving eculizumab and review of the literature
Background. Atypical hemolytic uremic syndrome (aHUS) is a rare and severe disease characterized by uncontrolled activation and dysregulation of the alternative complement pathway and development of thrombotic microangiopathy. Eculizumab, which is used as a first-line therapy in aHUS, blocks...
Shranjeno v:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Hacettepe University Institute of Child Health
2023-02-01
|
| Serija: | The Turkish Journal of Pediatrics |
| Teme: | |
| Online dostop: | https://turkjpediatr.org/article/view/15 |
| Oznake: |
Brez oznak, prvi označite!
|